This inventor holds 2 USPTO granted patents. Top assignees: Sato Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co.. Active years: 1989-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Urayasu, JP (1989)
- Shinagawa, JP (1995)
Company Filing History:
Years Active: 1989-1995
Title: Taizo Okada: Innovator in Pharmaceutical Preparations
Introduction
Taizo Okada is a notable inventor based in Shinagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid and external preparation compositions. With a total of 2 patents, his work has had a meaningful impact on medical treatments.
Latest Patents
One of Okada's latest patents is an aqueous suspension of sucralfate. This invention involves a stable aqueous suspension that includes sucralfate, starch, and various other components. The formulation is designed to protect ulcer areas on mucous membranes of the stomach and duodenum, providing a liquid pharmaceutical preparation that is industrially viable. Another significant patent is an external preparation composition that contains Ratanhia extract and/or Ratanhiaphenol. This composition is aimed at exhibiting antibacterial and antifungal actions against pathogenic bacteria and fungi, which are known to cause skin infections.
Career Highlights
Throughout his career, Taizo Okada has worked with reputable companies such as Sato Pharmaceutical Co., Ltd. and Chugai Pharmaceutical Co. These experiences have allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective medical solutions.
Collaborations
Okada has collaborated with notable coworkers, including Shigeo Morioka and Masahide Katayama. Their joint efforts have further advanced the research and development of pharmaceutical products.
Conclusion
Taizo Okada's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the field and offers valuable solutions for various health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile